Two insiders at Vivos Therapeutics, Inc. (VVOS) executed significant share purchases on April 2, 2026, totaling approximately $2.80 million. Michael C. Skaff acquired 1,044,777 shares at $1.34 per share, amounting to roughly $1.40 million. Concurrently, V-Co Investors 3 LLC also purchased 1,044,777 shares at the same price, representing another $1.40 million investment.
This coordinated buying activity, involving multiple insiders purchasing shares around the same time, is often interpreted as a strong bullish signal by market observers. Such cluster buying can indicate a shared confidence among company leadership regarding the company's future prospects.
The purchases come amid broader market activity and provide a notable data point for investors tracking insider sentiment within Vivos Therapeutics.